Varespladib methyl Terminated Phase 2 Trials for Coronavirus Disease 2019 (COVID‑19) / Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 Treatment

Indications	Status	Purpose	Phase
DBCOND0129755 (Coronavirus Disease 2019 (COVID‑19)) DBCOND0140934 (Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2)	Terminated	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT04969991	Study of Varespladib in Patients Hospitalized With Severe COVID-19	Varespladib methyl (DB05737)